Details for New Drug Application (NDA): 020389
✉ Email this page to a colleague
NDA 020389 describes MYCELEX-7 COMBINATION PACK, which is a drug marketed by Bayer Healthcare Llc and is included in one NDA. Additional details are available on the MYCELEX-7 COMBINATION PACK profile page.
The generic ingredient in MYCELEX-7 COMBINATION PACK is clotrimazole. There are eleven drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
The generic ingredient in MYCELEX-7 COMBINATION PACK is clotrimazole. There are eleven drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
Summary for 020389
| Tradename: | MYCELEX-7 COMBINATION PACK |
| Applicant: | Bayer Healthcare Llc |
| Ingredient: | clotrimazole |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020389
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM, TABLET;TOPICAL, VAGINAL | Strength | 1%,100MG | ||||
| Approval Date: | Jun 23, 1994 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
